American Society for Diagnostic and Interventional Nephrology (ASDIN) 17th Annual Scientific Meeting (VIRTUAL) Abstracts

Q3 Medicine

JAVA - Journal of the Association for Vascular Access Pub Date : 2022-01-01 DOI:10.1177/11297298221074835

C. Santos-Alonso, ME RiveroGorrín, H. SosaBarrios, Burguera Vion, Qureshi, DA Derylo

{"title":"American Society for Diagnostic and Interventional Nephrology (ASDIN) 17th Annual Scientific Meeting (VIRTUAL) Abstracts","authors":"C. Santos-Alonso, ME RiveroGorrín, H. SosaBarrios, Burguera Vion, Qureshi, DA Derylo","doi":"10.1177/11297298221074835","DOIUrl":null,"url":null,"abstract":"We report the results of a retrospective review of 155 successfully created endovascular arteriovenous fistulas at the Dallas Nephrology Plano Vascular Access Center between May 2019 through October 2020 using 2 devices (Ellipsys and WavelinQ). Outcomes reported include brachial artery flow, number of secondary procedures, time to physiologic maturity and failure rate. These outcomes are reported for the whole group as well as for each of the Ellipsys, radial WavelinQ and ulnar WavelinQ fistulas. During the follow up period of the study, 33 (21.3%) fistulas failed and 101 (65.2%) reached physiologic maturity. Of those which reached physiologic maturity, 43 (42.6%) did so with zero secondary procedures, 40 (39.6%) with 1 secondary procedure, and 18 (17.8%) with 2 or more. The mean and median durations to physiologic maturity were 100.5 and 86 days, respectively. The mean and median number of secondary procedures to physiologic maturity were 0.8 and 1, respectively. Male gender and a higher immediate postoperative brachial artery flow were predictors of","PeriodicalId":35321,"journal":{"name":"JAVA - Journal of the Association for Vascular Access","volume":"65 3 1","pages":"NP1 - NP9"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAVA - Journal of the Association for Vascular Access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11297298221074835","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

We report the results of a retrospective review of 155 successfully created endovascular arteriovenous fistulas at the Dallas Nephrology Plano Vascular Access Center between May 2019 through October 2020 using 2 devices (Ellipsys and WavelinQ). Outcomes reported include brachial artery flow, number of secondary procedures, time to physiologic maturity and failure rate. These outcomes are reported for the whole group as well as for each of the Ellipsys, radial WavelinQ and ulnar WavelinQ fistulas. During the follow up period of the study, 33 (21.3%) fistulas failed and 101 (65.2%) reached physiologic maturity. Of those which reached physiologic maturity, 43 (42.6%) did so with zero secondary procedures, 40 (39.6%) with 1 secondary procedure, and 18 (17.8%) with 2 or more. The mean and median durations to physiologic maturity were 100.5 and 86 days, respectively. The mean and median number of secondary procedures to physiologic maturity were 0.8 and 1, respectively. Male gender and a higher immediate postoperative brachial artery flow were predictors of

查看原文本刊更多论文

美国诊断与介入肾脏病学会(ASDIN)第17届年度科学会议(VIRTUAL)摘要

我们报告了2019年5月至2020年10月期间在Dallas Nephrology Plano Vascular Access Center使用2种设备(Ellipsys和wavinq)成功创建的155例血管内动静脉瘘的回顾性审查结果。报道的结果包括肱动脉流量、二次手术次数、生理成熟时间和失败率。这些结果报告了整个组以及每一个椭圆、径向和尺侧的小波管。在随访期间，33例(21.3%)瘘管失败，101例(65.2%)达到生理成熟。在达到生理成熟的患者中，43例(42.6%)没有进行二次手术，40例(39.6%)进行了一次二次手术，18例(17.8%)进行了两次或以上的二次手术。生理成熟的平均和中位时间分别为100.5天和86天。生理成熟前二次手术的平均和中位数分别为0.8和1。男性和术后即刻肱动脉流量较高是预后因素

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAVA - Journal of the Association for Vascular Access Medicine-Medicine (miscellaneous)

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The Association for Vascular Access (AVA) is an association of healthcare professionals founded in 1985 to promote the emerging vascular access specialty. Today, its multidisciplinary membership advances research, professional and public education to shape practice and enhance patient outcomes, and partners with the device manufacturing community to bring about evidence-based innovations in vascular access.